Debora Barton
2023
In 2023, Debora Barton earned a total compensation of $1.7M as Former Chief Medical Officer at TScan Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $217,000 |
|---|---|
| Option Awards | $944,853 |
| Salary | $472,500 |
| Other | $75,643 |
| Total | $1,709,996 |
Barton received $944.9K in option awards, accounting for 55% of the total pay in 2023.
Barton also received $217K in non-equity incentive plan, $472.5K in salary and $75.6K in other compensation.
Rankings
In 2023, Debora Barton's compensation ranked 660th out of 3,006 executives tracked by ExecPay. In other words, Barton earned more than 78.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 660 out of 3,006 | 78th |
Division Manufacturing | 368 out of 1,650 | 78th |
Major group Chemicals And Allied Products | 252 out of 918 | 73rd |
Industry group Drugs | 248 out of 881 | 72nd |
Industry Biological Products, Except Diagnostic Substances | 84 out of 213 | 61st |
Source: SEC filing on April 30, 2024.
Barton's colleagues
We found four more compensation records of executives who worked with Debora Barton at TScan Therapeutics in 2023.